266 related articles for article (PubMed ID: 30840034)
21. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
22. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
[TBL] [Abstract][Full Text] [Related]
23. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy in patients with thin melanomas.
Cecchi R; Buralli L; Innocenti S; De Gaudio C
J Dermatol; 2007 Aug; 34(8):512-5. PubMed ID: 17683380
[TBL] [Abstract][Full Text] [Related]
25. Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.
Han D; Yu D; Zhao X; Marzban SS; Messina JL; Gonzalez RJ; Cruse CW; Sarnaik AA; Puleo C; Sondak VK; Zager JS
Ann Surg Oncol; 2012 Oct; 19(11):3335-42. PubMed ID: 22766986
[TBL] [Abstract][Full Text] [Related]
26. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
27. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
28. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
Chu VH; Tetzlaff MT; Torres-Cabala CA; Prieto VG; Bassett R; Gershenwald JE; McLemore MS; Ivan D; Wang WL; Ross MI; Curry JL
Biomed Res Int; 2013; 2013():898719. PubMed ID: 24369020
[TBL] [Abstract][Full Text] [Related]
29. Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study.
Verver D; Louwman WJ; Koljenović S; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Cancer; 2018 Mar; 92():100-107. PubMed ID: 29217356
[TBL] [Abstract][Full Text] [Related]
30. Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanoma.
Jacobs IA; Chang CK; DasGupta TK; Salti GI
Ann Surg Oncol; 2003 Jun; 10(5):558-61. PubMed ID: 12794023
[TBL] [Abstract][Full Text] [Related]
31. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
Appleton SE; Fadel Z; Williams JS; Bezuhly M
Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
[TBL] [Abstract][Full Text] [Related]
32. How staging of thin melanoma is changed after the introduction of TNM 7th edition: a population-based analysis.
Caldarella A; Fancelli L; Manneschi G; Chiarugi A; Nardini P; Crocetti E
J Cancer Res Clin Oncol; 2016 Jan; 142(1):73-6. PubMed ID: 26113451
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
Sekula-Gibbs SA; Shearer MA
Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
[TBL] [Abstract][Full Text] [Related]
35. Role of sentinel lymph node biopsy in patients with thin melanoma.
Andtbacka RH; Gershenwald JE
J Natl Compr Canc Netw; 2009 Mar; 7(3):308-17. PubMed ID: 19401063
[TBL] [Abstract][Full Text] [Related]
36. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
Bartlett EK; Gimotty PA; Sinnamon AJ; Wachtel H; Roses RE; Schuchter L; Xu X; Elder DE; Ming M; Elenitsas R; Guerry D; Kelz RR; Czerniecki BJ; Fraker DL; Karakousis GC
Ann Surg Oncol; 2014 Feb; 21(2):643-9. PubMed ID: 24121883
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.
Morton DL; Cochran AJ; Thompson JF; Elashoff R; Essner R; Glass EC; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Wang HJ;
Ann Surg; 2005 Sep; 242(3):302-11; discussion 311-3. PubMed ID: 16135917
[TBL] [Abstract][Full Text] [Related]
38. The importance of mitosis as a factor for predicting sentinel lymph node biopsy for thin melanoma.
Oliveira Filho RS; Jorge MC; Oliveira DA; Oliveira RL; Queiroz Mdo C; Nahas FX
An Bras Dermatol; 2011; 86(4 Suppl 1):S107-9. PubMed ID: 22068786
[TBL] [Abstract][Full Text] [Related]
39. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
Rousseau DL; Ross MI; Johnson MM; Prieto VG; Lee JE; Mansfield PF; Gershenwald JE
Ann Surg Oncol; 2003 Jun; 10(5):569-74. PubMed ID: 12794025
[TBL] [Abstract][Full Text] [Related]
40. Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases.
Piazzalunga D; Ceresoli M; Allievi N; Ribero S; Quaglino P; Di Lorenzo S; Corradino B; Campana LG; Mocellin S; Rossi CR;
Eur J Surg Oncol; 2019 May; 45(5):820-824. PubMed ID: 30527782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
